Showing 1 - 5 results of 5 for search 'Shuqun Cheng', query time: 0.01s Refine Results
  1. 1
    GCSA-SegFormer: Transformer-Based Segmentation for Liver Tumor Pathological Images

    GCSA-SegFormer: Transformer-Based Segmentation for Liver Tumor Pathological Images by Jingbin Wen, Sihua Yang, Weiqi Li, Shuqun Cheng

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial

    Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for... by Xubiao Wei, Yabo Jiang, Jinxue Zhou, Hongkun Zhou, Dong Qu, Xiaofei Ye, Yaxin Zheng, Shuqun Cheng

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis: A propensity score matching analysis

    Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastas... by Juxian Sun, Chang Liu, Xiandong Tao, Yu Yang, Hai Jin, Shuqun Cheng, Huazheng Shi, Maolin Yan, Jie Shi

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study

    Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study by Yitao Zheng, Jingna Hu, Yingna Mei, Yanjun Xiang, Haofeng Lu, Jiuting Zhu, Kaile Pan, Shuqun Cheng, Yang Liu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma

    The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma by Feifei Mao, Yuqiang Cheng, Kang Wang, Zongtao Chai, Lei Guo, Yanyan Xu, Xue Chen, Jie Shi, Weixing Guo, Junling Liu, Shuqun Cheng

    Published 2024-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: